Oseltamivir was also successfully used to treat an adult ITP patient who responded poorly to conventional therapies, including corticosteroids, intravenous immunoglobulin (IVIG), recombinant human thrombopoietin, rituximab, danazol, and vindesine (23). Here, THPO is linked to autoimmune thrombocytopenic purpura.